Yi Fang

4.6k total citations · 1 hit paper
123 papers, 3.5k citations indexed

About

Yi Fang is a scholar working on Nephrology, Molecular Biology and Surgery. According to data from OpenAlex, Yi Fang has authored 123 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Nephrology, 30 papers in Molecular Biology and 23 papers in Surgery. Recurrent topics in Yi Fang's work include Acute Kidney Injury Research (35 papers), Chronic Kidney Disease and Diabetes (15 papers) and MicroRNA in disease regulation (12 papers). Yi Fang is often cited by papers focused on Acute Kidney Injury Research (35 papers), Chronic Kidney Disease and Diabetes (15 papers) and MicroRNA in disease regulation (12 papers). Yi Fang collaborates with scholars based in China, United States and United Kingdom. Yi Fang's co-authors include Mingyu Liang, Xiaoqiang Ding, Alison J. Kriegel, Xiaofang Yu, Xiaoqiang Ding, Yong Liu, Xialian Xu, Nana Song, Jianzhou Zou and Jie Teng and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Scientific Reports.

In The Last Decade

Yi Fang

118 papers receiving 3.5k citations

Hit Papers

Temporal trends in prevalence and mortality for chronic k... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Fang China 33 1.6k 1.2k 972 547 322 123 3.5k
Michal Herman‐Edelstein Israel 19 1.1k 0.7× 534 0.5× 950 1.0× 621 1.1× 315 1.0× 33 2.9k
Yasuhiro Akai Japan 25 1.7k 1.1× 589 0.5× 1.1k 1.1× 441 0.8× 366 1.1× 79 3.8k
Ning Tan China 26 971 0.6× 708 0.6× 887 0.9× 441 0.8× 407 1.3× 229 3.1k
Gabriella Gruden Italy 39 1.3k 0.8× 375 0.3× 1.1k 1.1× 593 1.1× 360 1.1× 117 4.1k
Yaoming Xue China 35 1.3k 0.8× 532 0.5× 434 0.4× 387 0.7× 349 1.1× 159 3.2k
Hideo Yasuda Japan 29 1.2k 0.8× 304 0.3× 1.0k 1.1× 364 0.7× 306 1.0× 150 3.4k
Hyunjin Noh South Korea 32 1.1k 0.7× 328 0.3× 976 1.0× 577 1.1× 300 0.9× 104 3.0k
Shan Mou China 31 1.2k 0.7× 257 0.2× 1.3k 1.3× 376 0.7× 298 0.9× 108 3.1k
Zhaohong Chen China 29 973 0.6× 290 0.3× 966 1.0× 285 0.5× 305 0.9× 97 2.7k
Hui Peng China 35 1.4k 0.9× 374 0.3× 688 0.7× 781 1.4× 534 1.7× 205 4.2k

Countries citing papers authored by Yi Fang

Since Specialization
Citations

This map shows the geographic impact of Yi Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Fang more than expected).

Fields of papers citing papers by Yi Fang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Fang. The network helps show where Yi Fang may publish in the future.

Co-authorship network of co-authors of Yi Fang

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Fang. A scholar is included among the top collaborators of Yi Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Fang. Yi Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wu, Qian, et al.. (2025). Heavy metal burden in the urine and cancer risk. Frontiers in Oncology. 15. 1545118–1545118.
4.
Lu, Wei, Shi Cheng, Jiarui Xu, et al.. (2024). Roles of AhR/CYP1s signaling pathway mediated ROS production in uremic cardiomyopathy. Toxicology Letters. 396. 81–93. 3 indexed citations
6.
Fang, Yi, et al.. (2024). External Validation of the International Prognosis Prediction Model of IgA Nephropathy. Renal Failure. 46(1). 2313174–2313174. 3 indexed citations
7.
Xu, Haoran, Qingyu Zhu, Jing Zhao, et al.. (2023). Melatonin Inhibits Testosterone Synthesis in Rooster Leydig Cells by Targeting CXCL14 through miR-7481-3p. International Journal of Molecular Sciences. 24(23). 16552–16552. 4 indexed citations
8.
Liu, Yixin, Su Wang, Li Ding, et al.. (2022). Antimicrobial resistance patterns and genetic elements associated with the antibiotic resistance of Helicobacter pylori strains from Shanghai. Gut Pathogens. 14(1). 14–14. 27 indexed citations
10.
Xu, Sujuan, Edward Lee, Xiaoyan Wang, et al.. (2021). Perilipin 2 Impacts Acute Kidney Injury via Regulation of PPARα. Journal of Immunology Research. 2021. 1–12. 10 indexed citations
11.
Lu, Zhihui, Hong Liu, Nana Song, et al.. (2021). METTL14 aggravates podocyte injury and glomerulopathy progression through N6-methyladenosine-dependent downregulating of Sirt1. Cell Death and Disease. 12(10). 881–881. 90 indexed citations
12.
Chen, Shanshan, et al.. (2021). Long Non-Coding RNA: A Potential Strategy for the Diagnosis and Treatment of Colorectal Cancer. Frontiers in Oncology. 11. 762752–762752. 12 indexed citations
13.
Ning, Yichun, Jing Chen, Yiqin Shi, et al.. (2020). Genistein Ameliorates Renal Fibrosis Through Regulation Snail via m6A RNA Demethylase ALKBH5. Frontiers in Pharmacology. 11. 579265–579265. 59 indexed citations
14.
Ning, Yichun, Yiqin Shi, Jing Chen, et al.. (2018). Necrostatin-1 Attenuates Cisplatin-Induced Nephrotoxicity Through Suppression of Apoptosis and Oxidative Stress and Retains Klotho Expression. Frontiers in Pharmacology. 9. 384–384. 43 indexed citations
15.
Fang, Yi, et al.. (2017). miR‐382 Contributes to Renal Tubulointerstitial Fibrosis by Downregulating HSPD1. Oxidative Medicine and Cellular Longevity. 2017(1). 4708516–4708516. 23 indexed citations
16.
Yu, Xiaofang, Yi Fang, Jiaming Zhu, et al.. (2012). The balance of beneficial and deleterious effects of hypoxia-inducible factor activation by prolyl hydroxylase inhibitor in rat remnant kidney depends on the timing of administration. Nephrology Dialysis Transplantation. 27(8). 3110–3119. 65 indexed citations
17.
Xu, Xialian, Alison J. Kriegel, Yong Liu, et al.. (2012). Delayed ischemic preconditioning contributes to renal protection by upregulation of miR-21. Kidney International. 82(11). 1167–1175. 146 indexed citations
18.
Chen, Yuemei, Xiaoqiang Ding, Jie Teng, et al.. (2010). Serum Uric Acid Is Inversely Related to Acute Ischemic Stroke Morbidity in Hemodialysis Patients. American Journal of Nephrology. 33(2). 97–104. 16 indexed citations
19.
Tian, Zhongmin, Yong Liu, Kristie Usa, et al.. (2009). Novel Role of Fumarate Metabolism in Dahl-Salt Sensitive Hypertension. Hypertension. 54(2). 255–260. 65 indexed citations
20.
Jiang, Su, et al.. (2007). Renal protection by delayed ischaemic preconditioning is associated with inhibition of the inflammatory response and NF‐κB activation. Cell Biochemistry and Function. 25(3). 335–343. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026